Safety and efficacy of oral tacrolimus in the treatment of paediatric inflammatory bowel disease;Eficacia y seguridad de tacrolimus oral para el tratamiento de la enfermedad inflamatoria intestinal pediátrica

Anales de Pediatria

Volumn 70, Issue 6, 2009, Pages 519-525

  Navas Lopez V M ^a   Blasco Alonso, J ^a   Sierra Salinas, C ^a   Barco Galvez A ^a   Vicioso Recio, M I ^b  

^a HOSPITAL MATERNO INFANTIL   (Spain)

^b HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

Crohn's disease; Inflammatory bowel disease; Tacrolimus; Ulcerative colitis

Indexed keywords

AZATHIOPRINE; COTRIMOXAZOLE; CREATININE; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE; STEROID; TACROLIMUS;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; COLON RESECTION; CREATININE BLOOD LEVEL; CROHN DISEASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; IMMUNOMODULATION; MAINTENANCE THERAPY; MALE; PLASMA CONCENTRATION-TIME CURVE; PRESCHOOL CHILD; REMISSION; RETROSPECTIVE STUDY; SCHOOL CHILD; SIDE EFFECT; THERAPY DELAY; TREATMENT DURATION; ULCERATIVE COLITIS;

ADMINISTRATION, ORAL; ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; MALE; RETROSPECTIVE STUDIES; TACROLIMUS; TREATMENT OUTCOME;

EID: 67849094126     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1016/j.anpedi.2009.03.005     Document Type: Article

References (25)

1. J. De Oca, L. Vilar, J. Castellote, R. Sánchez Santos, D. Parés, and S. Biondo Immunomodulation with tacrolimus (FK 506): Results of a prospective, open-label, non-controlled trial in patients with inflammatory bowel disease Rev Esp Enferm Dig 95 2003 459 464
2. D. Kelly, P. Jara, B. Rodeck, P. Lykavieris, M. Burdelski, and M. Becker Tacrolimus and steroids versus ciclosporin microemulsion, steroids, and azathioprine in children undergoing liver transplantation: Randomised european multicentre trial Lancet 364 2004 1054 1061
3. F. Hernández, M. López Santamaría, M. Gámez, J. Murcia, N. Leal, and G. Prieto Results of an intestinal transplantation program in Spain. Five years later Cir Pediatr 17 2004 145 148
4. G.L. Plosker, and R.H. Foster Tacrolimus: A further update of its pharmacology and therapeutic use in the management of organ transplantation Drugs 59 2000 323 389
5. S. Gulati, N. Prasad, R.K. Sharma, A. Kumar, A. Gupta, and V.P. Baburaj Tacrolimus: A new therapy for steroid-resistant nephrotic syndrome in children Nephrol Dial Transplant 23 2008 910 913
6. F.S. Larsen, B. Vainer, M. Eefsen, P.N. Bjerring, and B. Adel Hansen Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis World J Gastroenterol 13 2007 3232 3236
7. A. Bousvaros, A.M. Leichtner, L. Book, A. Shigeoka, J. Bilodeau, and E. Semeao Treatment of pediatric autoimmune enteropathy with tacrolimus (FK506) Gastroenterology 111 1996 237 243
8. D. Chow, and R. Leong The use of tacrolimus in the treatment of inflammatory bowel disease Expert Opin Drug Saf 6 2007 479 485
9. J.S. Hyams, G.D. Ferry, F.S. Mandel, J.D. Gryboski, P.M. Kibort, and B.S. Kirschner Development and validation of a pediatric Crohn's disease activity index J Pediatr Gastroenterol Nutr 12 1991 439 447
10. M. Castro, B. Papadatou, E. Ceriati, Knafeltz, P. De Angelis, and F. Ferreti Role of cyclosporin in preventing or delaying colectomy in children with severe ulcerative colitis Langenbecks Arch Surg 392 2007 161 164
11. A.P. Eidelwein, C. Cuffari, V. Abadom, and M. Oliva-Hemker Infliximab efficacy in pediatric ulcerative colitis Inflamm Bowel Dis 11 2005 213 218
12. J. Hyams, W. Crandall, S. Kugathasan, A. Griffiths, A. Olson, J. Johanns REACH Study Group Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children Gastroenterology 132 2007 863 873 (Pubitemid 46454266)
13. A. Bousvaros, A. Wang, and A.M. Leichtner Tacrolimus (FK-506) treatment of fulminant colitis in a child J Pediatr Gastroenterol Nutr 23 1996 329 333
14. P.W. Lowry, A.L. Weaver, W.J. Tremaine, and W.J. Sandborn Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment-refractory Crohn's disease perianal fistulae Inflamm Bowel Dis 5 1999 239 245
15. W.J. Sandborn, D.H. Present, K.L. Isaacs, D.C. Wolf, E. Greenberg, and S.B. Hanauer Tacrolimus for the treatment of fistulas in patients with Crohn's disease: A randomized, placebo-controlled trial Gastroenterology 125 2003 380 388
16. Y. González-Lama, L. Abreu, M.I. Vera, M. Pastrana, S. Tabernero, and J. Revilla Long-term oral tacrolimus therapy in refractory to infliximab fistulising Crohn's disease: A pilot study Inflamm Bowel Dis 11 2005 8 15
17. S.C. Ng, N. Arebi, and M.A. Kamm Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease Inflamm Bowel Dis 13 2007 129 134
18. Y. González-Lama, J.P. Gisbert, and J. Mate The role of tacrolimus in inflammatory bowel disease: A systematic review Dig Dis Sci 51 2006 1833 1840
19. K. Fellermann, Z. Tanko, K.R. Herrlinger, T. Witthoeft, N. Homann, and A. Bruening Response of refractory colitis to intravenous or oral tacrolimus (FK506) Inflamm Bowel Dis 8 2002 317 324
20. C. Högenauer, H.H. Wenzl, T.A. Hinterleitner, and W. Petritsch Effect of oral tacrolimus (FK506) on steroid-refractory moderate/severe ulcerative colitis Aliment Pharmacol Ther 18 2003 415 423
21. A. Bousvaros, B.S. Kirschner, S.L. Werlin, L. Parker-Hartigan, F. Daum, and K.B. Freeman Oral tacrolimus treatment of severe colitis in children J Pediatr 137 2000 794 799
22. D.A. Ziring, S.S. Wu, W.S. Mow, M.G. Martin, M. Mehra, and M.E. Ament Oral tacrolimus for steroid-dependent and steroid-resistant ulcerative colitis in children J Pediatr Gastroenterol Nutr 45 2007 306 311
23. D. Turner, C.M. Walsh, E.I. Benchimol, E.H. Mann, K.E. Thomas, and C. Chow Severe paediatric ulcerative colitis: Incidence, outcomes and optimal timing for second-line therapy Gut 57 2008 331 338
24. J.H. Vargas Role of tacrolimus as primary therapy in moderate to severe ulcerative colitis in pediatrics Gastroenterology 120 2001 A625
25. H. Ogata, T. Matsui, M. Nakamura, M. Iida, M. Takazoe, and Y. Suzuki A randomised dose finding study of oral tacrolimus (FK506) therapy in refractory ulcerative colitis Gut 55 2006 1255 1262